The maintenance of a minimal level of CCL2 following AFSC treatment, may be critical for the protection of the homeostatic arm of the CCL2/CCR2 signaling pathway which not only participates in immune cell recruitment to areas of infection but also osteoclast differentiation and metabolic regulation [61], [71], [72]. This evidence concerns the gene CCL2 and infection.